Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125, STF2.HA1 SI).

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Vaccine

• Publication date

  2011-07-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.vaccine.2011.05.001PMID 21596084
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled trial.

  2011cited by this paper
• Global burden and investment for neglected diseases?

  2010cited by this paper
• Safety and immunogenicity of a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125) in healthy young adults.

  2010cited by this paper
• Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model

  2010cited by this paper
• Age-Associated Decrease in TLR Function in Primary Human Dendritic Cells Predicts Influenza Vaccine Response

  2010cited by this paper
• Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older.

  2009cited by this paper
• The imperative of influenza vaccines for elderly individuals-an evolving story.

  2009cited by this paper
• Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin.

  2008cited by this paper
• Efficacious Recombinant Influenza Vaccines Produced by High Yield Bacterial Expression: A Solution to Global Pandemic and Seasonal Needs

  2008cited by this paper
• Mortality benefits of influenza vaccination in elderly people: an ongoing controversy.

  2007cited by this paper
• The annual impact of seasonal influenza in the US: measuring disease burden and costs.

  2007cited by this paper
• Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity.

  2007cited by this paper
• Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).

  2006cited by this paper
• Antibody response to influenza vaccination in the elderly: a quantitative review.

  2006cited by this paper
• Toll-dependent selection of microbial antigens for presentation by dendritic cells

  2006cited by this paper
• Vaccines for preventing influenza in healthy adults.

  2004cited by this paper
• Regulation of Phagosome Maturation by Signals from Toll-Like Receptors

  2004cited by this paper
• Impact of glycosylation on the immunogenicity of a DNA-based influenza H5 HA vaccine.

  2003cited by this paper
• Mortality associated with influenza and respiratory syncytial virus in the United States.

  2003cited by this paper
• DIAGNOSIS OF LEGIONELLA INFECTION

  2002cited by this paper
• The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine.

  2001cited by this paper
• Importance of hemagglutinin glycosylation for the biological functions of influenza virus.

  2001cited by this paper
• Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).

  2000cited by this paper
• The Number and Location of Glycans on Influenza Hemagglutinin Determine Folding and Association with Calnexin and Calreticulin

  1997cited by this paper
• Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections

  1989cited by this paper

• Flagellin fusion proteins as self-adjuvanting vaccines for viral infections and cancer

  2026cites this paper
• Targeting immunosenescence and inflammaging: advancing longevity research

  2025cites this paper
• Toll-like receptors (TLRs) in the trained immunity era

  2025cites this paper
• FliC adjuvant augments protective efficacy of recombinant T2544 antigen against SalmonellaTyphiand Paratyphi A by increasing serum antibodies, intestinal secretory immunoglobulin A and T cell memory.

  2025cites this paper
• Structural engineering of flagellin as vaccine adjuvant: quest for the minimal domain of flagellin for TLR5 activation

  2025cites this paper
• Toll‐like receptor expression during inflammatory processes in human diseases

  2025cites this paper
• Flagellin in the human gut microbiome is a diet-adjustable adjuvant for vaccination

  2025cites this paper
• Flagellin as a Versatile Adjuvant Platform: Genetic Fusion Approaches for Next-Generation Vaccines

  2025cites this paper
• Flagellin engineering enhances CAR-T cell function by reshaping tumor microenvironment in solid tumors

  2025cites this paper
• Balancing harm and harmony: Evolutionary dynamics between gut microbiota-derived flagellin and TLR5-mediated host immunity and metabolism

  2025cites this paper
• Flagellins as Vaccine Adjuvants and Cancer Immunotherapy: Recent Advances and Future Prospects

  2025cites this paper
• Influenza Virus: Global Health Impact, Strategies, Challenges, Role of Nanotechnolgy in Influenza Vaccine Development

  2025cites this paper
• Rescue of bacterial motility using two- and three-species FliC chimeras

  2025cites this paper
• Exploiting bacterial-origin immunostimulants for improved vaccination and immunotherapy: current insights and future directions

  2024cites this paper
• Flagellate bacteria‐mediated tumour antigen delivery: A novel approach to enhance dendritic cell activation for in situ cancer vaccination

  2024cites this paper
• Inserting CTL Epitopes of the Viral Nucleoprotein to Improve Immunogenicity and Protective Efficacy of Recombinant Protein against Influenza A Virus

  2024cites this paper
• The role of the gut microbiota in regulating responses to vaccination: current knowledge and future directions

  2024cites this paper
• Nanomaterial Delivery Vehicles for the Development of Neoantigen Tumor Vaccines for Personalized Treatment

  2024cites this paper
• Enhancing vaccine effectiveness in the elderly to counter antibiotic resistance: The potential of adjuvants via pattern recognition receptors

  2024cites this paper
• TLR5-deficiency controls dendritic cell subset development in an autoimmune diabetes-susceptible model

  2024cites this paper
• Novel adjuvants in allergen-specific immunotherapy: where do we stand?

  2024cites this paper
• Mucosal TLR5 activation controls healthspan and longevity

  2024cites this paper
• A Perspective on Current Flavivirus Vaccine Development: A Brief Review

  2023cites this paper
• PLGA nanoparticles containing Intimin-Flagellin fusion protein for E. coli O157:H7 nano-vaccine.

  2023cites this paper
• Deimmunization of flagellin adjuvant for clinical application.

  2023cites this paper
• Structural Insights into Type III Secretion Systems of the Bacterial Flagellum and Injectisome.

  2023cites this paper
• TLR agonists as vaccine adjuvants in the prevention of viral infections: an overview

  2023cites this paper
• Enhanced immunogenicity elicited by a novel DNA vaccine encoding the SARS-CoV-2 S1 protein fused to the optimized flagellin of Salmonella typhimurium in mice

  2023cites this paper
• A flagellin-conjugate protein induces dual NLRC4- and NLRP3-inflammasome activation which modulates inflammatory cytokine secretion from macrophages

  2023cites this paper
• Adjuvant physiochemistry and advanced nanotechnology for vaccine development.

  2023cites this paper
• Advances in Infectious Disease Vaccine Adjuvants

  2022influential citation
• Recent Progress in Recombinant Influenza Vaccine Development Toward Heterosubtypic Immune Response

  2022cites this paper
• Recent Advances in the Development of Toll-like Receptor Agonist-Based Vaccine Adjuvants for Infectious Diseases

  2022cites this paper
• Blood transcriptome analysis revealing aging gene expression profiles in red panda

  2022cites this paper
• Protein-Based Adjuvants for Vaccines as Immunomodulators of the Innate and Adaptive Immune Response: Current Knowledge, Challenges, and Future Opportunities

  2022cites this paper
• Structural basis of bacterial flagellin for NAIP5 binding and NLRC4 inflammasome activation and the mechanism of flagellin induced release of cytokines <i>in vivo</i>

  2022cites this paper
• Identification and analysis of B cell epitopes of hemagglutinin of H1N1 influenza virus

  2022cites this paper
• Stimulation of naïve B cells with a fusion protein consisting of FlaA and Bet v 1 induces regulatory B cells ex vivo

  2022cites this paper
• Vaccines and Vaccination Strategies for Older Adults

  2021cites this paper
• Factors influencing the immunogenicity of influenza vaccines

  2021cites this paper
• Anti-Viral Pattern Recognition Receptors as Therapeutic Targets

  2021cites this paper
• Immunesenescence: A Predisposing Risk Factor for the Development of COVID-19?

  2020cites this paper
• Next-generation influenza vaccines: opportunities and challenges

  2020cites this paper
• Vaccines to Prevent Infectious Diseases in the Older Population: Immunological Challenges and Future Perspectives

  2020cites this paper
• Toward precision adjuvants: optimizing science and safety

  2020cites this paper
• Fusion of Bacterial Flagellin to a Dendritic Cell-Targeting αCD40 Antibody Construct Coupled With Viral or Leukemia-Specific Antigens Enhances Dendritic Cell Maturation and Activates Peptide-Responsive T Cells

  2020cites this paper
• Advances in Oral Subunit Vaccine Design

  2020cites this paper
• A Decade in Review: A Systematic Review of Universal Influenza Vaccines in Clinical Trials during the 2010 Decade

  2020cites this paper
• Pattern recognition receptors as potential drug targets in inflammatory disorders.

  2020cites this paper
• Modulation of the Innate Immune Response by Targeting Toll-like Receptors: A Perspective on their Agonists and Antagonists.

  2020cites this paper
• In Silico Approach in Designing a Novel Multi-Epitope Vaccine Candidate against Non-Small Cell Lung Cancer with Overexpressed G Protein-Coupled Receptor 56

  2020cites this paper
• The optimized fusion protein HA1–2‐FliC&Dgr;D2D3 promotes mixed Th1/Th2 immune responses to influenza H7N9 with low induction of systemic proinflammatory cytokines in mice

  2019cites this paper
• Escherichia coli expressed flagellin C (FliC) of Salmonella Typhi improved the protective efficacy of YopE against plague infection.

  2019cites this paper
• Application of built-in adjuvants for epitope-based vaccines

  2019cites this paper
• Psychopharmacology: neuroimmune signaling in psychiatric disease-developing vaccines against abused drugs using toll-like receptor agonists

  2019cites this paper
• Glycosylation of the HIV-1 Env V1V2 loop to form a native-like structure may not be essential with a nanoparticle vaccine

  2019cites this paper
• Mucosal Vaccine Approaches for Prevention of HIV and SIV Transmission.

  2019cites this paper
• Localization Analysis of Heterophilic Antigen Epitopes of H1N1 Influenza Virus Hemagglutinin

  2019cites this paper
• Toll-Like Receptors and Relevant Emerging Therapeutics with Reference to Delivery Methods

  2019cites this paper
• The N‐terminal D1 domain of Treponema pallidum flagellin binding to TLR5 is required but not sufficient in activation of TLR5

  2019cites this paper
• 1 TLR Agonist Conjugation : A Chemical Perspective

  2019cites this paper
• Nanoparticles in influenza subunit vaccine development: Immunogenicity enhancement

  2019cites this paper
• Rapid Bladder Interleukin-10 Synthesis in Response to Uropathogenic Escherichia coli Is Part of a Defense Strategy Triggered by the Major Bacterial Flagellar Filament FliC and Contingent on TLR5

  2019cites this paper
• Immunomodulation as a Novel Strategy for Prevention and Treatment of Bordetella spp. Infections

  2019cites this paper
• Self-Adjuvanted Nanoparticle Based Vaccines for Poultry Viral Respiratory Diseases

  2018cites this paper
• Fusion proteins of flagellin and the major birch pollen allergen Bet v 1 show enhanced immunogenicity, reduced allergenicity, and intrinsic adjuvanticity

  2018cites this paper
• University of Intestinal CD103CD11b cDC2 Conventional Dendritic Cells Are Required for Primary CD4 T and B Cell Responses to Soluble Flagellin

  2018cites this paper
• CD103+CD11b+ mucosal classical dendritic cells initiate long-term switched antibody responses to flagellin

  2018cites this paper
• Infection Prevention: Oil- and Lipid-Containing Products in Vaccinology

  2018cites this paper
• Establishment of a novel safety assessment method for vaccine adjuvant development.

  2018cites this paper
• Opinion: Making Inactivated and Subunit-Based Vaccines Work

  2018cites this paper
• Intestinal CD103+CD11b+ cDC2 Conventional Dendritic Cells Are Required for Primary CD4+ T and B Cell Responses to Soluble Flagellin

  2018cites this paper
• Flagellin as a vaccine adjuvant

  2018cites this paper
• Toll-like Receptor Agonist Conjugation: A Chemical Perspective.

  2018cites this paper
• Immunopharmacology and Immunotoxicology Assessment of Vaccines and Adjuvants

  2018cites this paper
• 6 – Evolution of Adjuvants Across the Centuries

  2018cites this paper
• Recent clinical trends in Toll‐like receptor targeting therapeutics

  2018cites this paper
• Flagellin-fused protein targeting M2e and HA2 induces potent humoral and T-cell responses and protects mice against various influenza viruses a subtypes

  2018cites this paper
• Crystal structure of Bacillus cereus flagellin and structure-guided fusion-protein designs

  2018cites this paper
• University of Birmingham Intestinal CD103CD11b cDC2 Conventional Dendritic Cells Are Required for Primary CD4 T and B Cell Responses to Soluble Flagellin

  2018cites this paper
• A self-adjuvanted nanoparticle based vaccine against infectious bronchitis virus

  2018cites this paper
• Reduced dynamic range of antiviral innate immune responses in aging

  2017cites this paper
• Biotechnology approaches to produce potent, self-adjuvanting antigen-adjuvant fusion protein subunit vaccines.

  2017cites this paper
• Innate Immunosenescence and Its Impact on Health in Old Age

  2017cites this paper
• PERSPECTIVE DIRECTION OF USING FLAGELLIN BASED DRUGS

  2017cites this paper
• Protein nanovaccine confers robust immunity against Toxoplasma

  2017influential citation
• Conjugation of wildtype and hypoallergenic mugwort allergen Art v 1 to flagellin induces IL-10-DC and suppresses allergen-specific TH2-responses in vivo

  2017cites this paper
• Flagellins as Adjuvants of Vaccines

  2017cites this paper
• Bioconjugation Approaches to Producing Subunit Vaccines Composed of Protein or Peptide Antigens and Covalently Attached Toll-Like Receptor Ligands.

  2017cites this paper
• Bacterial flagellin—a potent immunomodulatory agent

  2017cites this paper
• Candidate vaccine construction against tick-born encephalitis based on hybrid recombinant flagG-protE-protein

  2017cites this paper
• A Novel R848-Conjugated Inactivated Influenza Virus Vaccine Is Efficacious and Safe in a Neonate Nonhuman Primate Model

  2016cites this paper
• Advances in Antiviral Therapies Targeting Toll-like Receptors

  2016cites this paper
• Dengue vaccine: an update on recombinant subunit strategies.

  2016cites this paper
• Review of Approaches to Caries Treatment

  2016cites this paper
• Phase 1 Safety and Immunogenicity Study of a Quadrivalent Seasonal Flu Vaccine Comprising Recombinant Hemagglutinin-Flagellin Fusion Proteins

  2016cites this paper
• Adjuvanting an inactivated influenza vaccine with flagellin improves the function and quantity of the long-term antibody response in a nonhuman primate neonate model.

  2016cites this paper
• Functional properties of flagellin as a stimulator of innate immunity

  2016cites this paper
• Toll-like receptors: the swiss army knife of immunity and vaccine development

  2016cites this paper
• The Effectiveness of Influenza Vaccination in Different Groups

  2016cites this paper